Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review
Colorectal cancer (CRC) continues to be one of the most prevalent and deadliest forms of cancer worldwide, despite notable advancements in its management. The prognosis for metastatic CRC remains discouraging, with a relative 5-year survival rate for stage IV CRC patients. Conventional treatments fo...
| 出版年: | International Journal of Pharmaceutics |
|---|---|
| 第一著者: | |
| フォーマット: | Review |
| 言語: | English |
| 出版事項: |
Elsevier B.V.
2024
|
| オンライン･アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85181882337&doi=10.1016%2fj.ijpharm.2023.123735&partnerID=40&md5=a6c0fe8ff883fc14b62d5c95d8a58466 |